IDO MUTANTS CROSS RESISTANT TO TYPE-I INTERFERON RETAIN P91-DEPENDENT GENE INDUCTION

被引:4
作者
KLEIN, SB
YEIVIN, A
BECKER, G
TAYLOR, MW
机构
[1] Department of Biology, Indiana University, Bloomington, Indiana
[2] Department of Biochemistry, Hebrew University, Jerusalem
[3] Eli Lilly, Indianapolis, Indiana
来源
JOURNAL OF INTERFERON RESEARCH | 1994年 / 14卷 / 06期
关键词
D O I
10.1089/jir.1994.14.333
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Genetic analyses of mutants have yielded valuable information about p91-associated interferon signal transduction. It was thus discovered that p91 is an essential protein for the induction of both type I and type II interferons, We previously reported the development of ME180 mutants resistant to interferon-gamma because of a signaling defect resulting in the loss of IDO induction, IDO does not respond to type I interferon despite an ISRE-like sequence upstream of the coding region, However, the IDO mutants were found to be cross-resistant to the growth-inhibitory effects of type I interferon, We therefore examined the effects of both types of interferon on interferon-stimulated gene mRNA accumulation and examined alterations in cellular protein introduced by the mutation, The induction of the p91-responsive gene 6-16 was not altered in either of the mutants, and the early-induced gene IRF1 exhibited differences only in the kinetics of mRNA accumulation, The later induced gene, p68, also exhibited different kinetics, possibly reflecting the changes in IRF1, Immunoprecipitated p91 exhibited normal, interferon-induced phosphorylation in both mutants, Two-dimensional gel electrophoresis revealed that the mutant cells contained 20 peptides with altered biochemistry, These results suggest that IDO induction is controlled by a distinct set of proteins not directly correlated with p91 activation,
引用
收藏
页码:333 / 341
页数:9
相关论文
共 41 条
  • [1] DIFFERENTIAL RESPONSE OF THE HUMAN 6-16 AND 9-27 GENES TO ALPHA-INTERFERON AND GAMMA-INTERFERON
    ACKRILL, AM
    REID, LE
    GILBERT, CS
    GEWERT, DR
    PORTER, ACG
    LEWIN, AR
    STARK, GR
    KERR, IM
    [J]. NUCLEIC ACIDS RESEARCH, 1991, 19 (03) : 591 - 598
  • [2] BARON S, 1992, INTRO INTERFERON SYS
  • [3] STRUCTURE OF 2 FORMS OF THE INTERFERON-INDUCED (2-'-5-') OLIGO-A SYNTHETASE OF HUMAN-CELLS BASED ON CDNAS AND GENE-SEQUENCES
    BENECH, P
    MORY, Y
    REVEL, M
    CHEBATH, J
    [J]. EMBO JOURNAL, 1985, 4 (09) : 2249 - 2256
  • [4] SYNERGISTIC INDUCTION OF POLYPEPTIDES BY TUMOR-NECROSIS-FACTOR AND INTERFERON-GAMMA IN CELLS SENSITIVE OR RESISTANT TO TUMOR-NECROSIS-FACTOR - ASSESSMENT BY COMPUTER-BASED ANALYSIS OF 2-DIMENSIONAL GELS USING THE PDQUEST SYSTEM
    BERESINI, MH
    SUGARMAN, BJ
    SHEPARD, HM
    EPSTEIN, LB
    [J]. ELECTROPHORESIS, 1990, 11 (03) : 232 - 241
  • [5] DIFFERENTIAL KINETICS OF POLYPEPTIDE EXPRESSION AND DIFFERENT BIOLOGICAL-ACTIVITIES IN THE HUMAN FIBROBLAST RESPONSE TO DSRNA OR INTERFERON TREATMENT
    BOURGEADE, MF
    LAURENTWINTER, C
    BESANCON, F
    THANG, MN
    MEMET, S
    [J]. JOURNAL OF INTERFERON RESEARCH, 1993, 13 (03): : 175 - 186
  • [6] EVIDENCE THAT TYPE-I AND TYPE-II INTERFERONS HAVE DIFFERENT RECEPTORS
    BRANCA, AA
    BAGLIONI, C
    [J]. NATURE, 1981, 294 (5843) : 768 - 770
  • [7] BRAVO R, 1982, CLIN CHEM, V28, P949
  • [8] CELIS JE, 1987, LEUKEMIA, V1, P800
  • [9] CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
  • [10] DAI W, 1990, J BIOL CHEM, V262, P861